Remote patient monitoring can help detect early health changes among lung transplant recipients in their first year after discharge, Mayo Clinic researchers found.
During the 12-month study, published April 30 in the Journal of Heart and Lung Transplantation Open, researchers monitored 116 lung transplant recipients who lived a median 234 miles from Mayo Clinic in Rochester. Minn., and who used a home device kit to track data including lung function, vital signs and weight. Almost 470 alerts were sent to the care team during the study period, without about a quarter prompting care changes such as earlier visits, medication adjustments or emergency evaluation.
“These findings provide important real-world evidence supporting the use of remote patient monitoring in lung transplant recipients,” said Kelly Pennington, M.D., co-senior author and pulmonologist at Mayo Clinic, in an April 30 news release. “As these models evolve, they have the potential to transform how we deliver transplant care — expanding access, reducing burden and improving outcomes for patients.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
